Cite

HARVARD Citation

    Fleischmann, D. et al. (n.d.). OC-0280 ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma. Radiotherapy and oncology. pp. S138-S139. [Online]. 
  
Back to record